文献速递肾癌与肾肿瘤

孤立性淋巴结受累肾细胞癌:长期自然史及手术切除后肿瘤学结局预测因素

Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
PubMed 文献 · Eur Urol · 2017-01-13

该研究回顾了1980至2010年间138例接受部分或根治性肾切除及淋巴结清扫的孤立性pN1M0肾细胞癌患者,中位随访8.5年。5年和10年无转移生存率分别为16%和15%,中位转移时间仅4.2个月。多因素分析显示症状、下腔静脉瘤栓、透明细胞及集合管/非特指组织学亚型、pT4分期和凝固性肿瘤坏死与转移独立相关。

要点

  • 孤立性pN1M0肾细胞癌手术切除后5年无转移生存率仅16%,但小部分患者可获长期生存。
  • 中位转移时间仅4.2个月,术后早期即需密切监测。
  • 症状、下腔静脉瘤栓、透明细胞及集合管/非特指亚型、pT4和凝固性肿瘤坏死为转移独立预测因素。

核心结论

  • 尽管孤立性pN1病变预后较差,但小部分患者在孤立性淋巴转移手术切除后可获得持久长期生存。
  • 不良预后特征可能有助于患者风险分层并促进多模式管理。

研究设计与样本

  • 回顾性研究,纳入1980年至2010年间138例接受部分或根治性肾切除及淋巴结清扫的孤立性pN1M0肾细胞癌患者。
  • 采用Kaplan-Meier法估计无转移生存、癌症特异性生存和总生存,采用Cox回归模型评估临床病理特征与肿瘤学结局的关联。

主要发现

  • 幸存者中位随访8.5年,5年和10年无转移生存率分别为16%和15%,癌症特异性生存率分别为26%和21%,总生存率分别为25%和15%。
  • 转移发生的中位时间仅为4.2个月。
  • 多因素分析中,就诊时有症状(HR 2.40;p=0.03)、下腔静脉瘤栓(HR 1.99;p=0.003)、透明细胞组织学亚型(HR 2.21;p=0.01)、集合管/非特指组织学亚型(HR 4.28;p<0.001)、pT4分期(HR 2.64;p=0.005)和凝固性肿瘤坏死(HR 2.51;p<0.001)与转移发生独立相关。
  • 具有1、2、3和4至5个不良特征的患者术后1年无转移生存率分别为71%、63%、33%和7%。

临床怎么用

  • 作者认为不良预后特征可能增强患者风险分层并促进多模式管理。

局限性

  • 局限性包括手术选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal cell carcinoma (RCC) with isolated lymph node (LN) involvement has historically been associated with poor prognosis. However, a subset of patients may experience long-term survival. OBJECTIVE: To examine the natural history of RCC with isolated LN involvement following surgical resection with long-term follow-up, and to evaluate clinicopathologic features associated with disease progression and survival. DESIGN, SETTING, AND PARTICIPANTS: A total of 138 patients with isolated pN1M0 RCC underwent partial or radical nephrectomy and LN dissection from 1980 to 2010. INTERVENTION: Partial or radical nephrectomy with LN dissection. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival (OS) were estimated using the Kaplan-Meier method. Associations between clinicopathologic features and oncologic outcomes were evaluated using Cox regression models. RESULTS AND LIMITATIONS: Median follow-up among survivors was 8.5 yr. The 5-yr and 10-yr MFS, CSS, and OS rates were 16% and 15%, 26% and 21%, and 25% and 15%, respectively. The median time to development of metastases was only 4.2 mo. On multivariable analysis, symptoms at presentation (hazard ratio [HR] 2.40; p=0.03), inferior vena cava tumor thrombus (HR 1.99; p=0.003), clear cell (HR 2.21; p=0.01) and collecting duct/not otherwise specified (HR 4.28; p<0.001) histologic subtypes, pT4 stage (HR 2.64; p=0.005), and coagulative tumor necrosis (HR 2.51; p<0.001) were independently associated with development of metastases. MFS rates at 1 yr after surgery were 71%, 63%, 33%, and 7% for patients with one, two, three, and four to five adverse features, respectively. Limitations include surgical selection bias. CONCLUSIONS: Although isolated pN1 disease portends a poor prognosis, a small subset of patients experience durable long-term survival after surgical resection of isolated lymphatic metastases. Adverse prognostic features may enhance patient risk stratification and facilitate multimodal management approaches. PATIENT SUMMARY: Although isolated lymph node metastases portend a poor prognosis, a small subset of patients experience long-term survival following surgical resection.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Gershman B, Moreira DM, Thompson RH, et al. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017. PMID: 28094055. doi:10.1016/j.eururo.2016.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。